These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 26147393)
1. Complete resolution of refractory cutaneous arteritis by intravenous cyclophosphamide pulse therapy. Kawakami T; Okano T; Takeuchi S; Kimura S; Soma Y Int J Dermatol; 2015 Aug; 54(8):e323-5. PubMed ID: 26147393 [No Abstract] [Full Text] [Related]
2. Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa. Okano T; Takeuchi S; Soma Y; Suzuki K; Tsukita S; Ishizu A; Suzuki K; Kawakami T J Dermatol; 2017 Jan; 44(1):18-22. PubMed ID: 27345569 [TBL] [Abstract][Full Text] [Related]
3. Therapy-resistant chronic leg ulcers. Johanna K; Jan-Christoph S; Harald V J Dtsch Dermatol Ges; 2015 Aug; 13(8):825-8. PubMed ID: 26213826 [No Abstract] [Full Text] [Related]
4. [Therapy and prognosis of medium and small vessel vasculitis]. Muso E Nihon Jinzo Gakkai Shi; 2014; 56(2):105-16. PubMed ID: 24730348 [No Abstract] [Full Text] [Related]
5. Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis. Dhaygude A; Griffith M; Cairns T; McLean A; Palmer A; Taube D Nephron Clin Pract; 2004; 97(4):c154-9. PubMed ID: 15331939 [TBL] [Abstract][Full Text] [Related]
6. Dramatic aneurysm regression in polyarteritis nodosa following high dose pulse cyclophosphamide. Raza K; Carruthers DM; Exley AR; Thambyrajah J; Bacon PA; Rowe IF J Rheumatol; 2000 May; 27(5):1320-1. PubMed ID: 10813312 [No Abstract] [Full Text] [Related]